| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/06/2010 | CN100577672C Ruthenium-anthraquinone conjugates, preparation method thereof and application for the same used as optical power therapeutic photosensitizer |
| 01/06/2010 | CN100577666C Thienopyridines as allosteric potentiators of the M4 muscarinic receptor |
| 01/06/2010 | CN100577665C Antineoplastic active canthardin derivative and method for preparing same |
| 01/06/2010 | CN100577664C Spirocyclic cyclohexane derivatives |
| 01/06/2010 | CN100577662C Setron-like compounds, preparation method and medicament use thereof |
| 01/06/2010 | CN100577661C Process for preparing substituted 8-azabicyclo[3.2.1] octan-3-ols |
| 01/06/2010 | CN100577660C N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists used for the treatment of diabetes |
| 01/06/2010 | CN100577658C 喹唑啉衍生物 Quinazoline derivatives |
| 01/06/2010 | CN100577657C Amorphous object of cinnamide compound |
| 01/06/2010 | CN100577655C Andrographolidi natrii bisulfis and preparation method thereof |
| 01/06/2010 | CN100577653C Process for producing dibenzo thionitrogen tropilidine derivative |
| 01/06/2010 | CN100577651C Lactam compound and medicinal use thereof |
| 01/06/2010 | CN100577648C 2H- or 3H-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof |
| 01/06/2010 | CN100577633C CaSR antagonist |
| 01/06/2010 | CN100577631C Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment the anti-cancer activity of DNA-damaging treatments |
| 01/06/2010 | CN100577623C Depigmentation agents |
| 01/06/2010 | CN100577212C Function of E4BP4 gene in embryo implantation course and application thereof |
| 01/06/2010 | CN100577198C Medicine for curing cardio-cerebrovascular disease |
| 01/06/2010 | CN100577185C Chinese medicine red sage-astragalus root preparation for treating liver fibrosis and liver cirrhosis and its preparation process |
| 01/06/2010 | CN100577183C Lipoic acid health food and application thereof |
| 01/06/2010 | CN100577179C Application of chitin, chitosan and their derivatives in preparing antivirotic |
| 01/06/2010 | CN100577178C Soft capsules containing roxithromycin |
| 01/06/2010 | CN100577177C Medical combination of teniposide, the preparing method and use thereof |
| 01/06/2010 | CN100577176C Extractive of Chinese globeflower in short petal, effective content of anti inflammation and usage |
| 01/06/2010 | CN100577175C Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
| 01/06/2010 | CN100577174C Compositions containing defined oxidized phospholipids |
| 01/06/2010 | CN100577173C Adefovir dipivoxil self-emulsifiable preparation and its preparing method |
| 01/06/2010 | CN100577172C Pharmaceutical compositions for treatment of metabolic bone disease and preparation method thereof |
| 01/06/2010 | CN100577171C Medicament for treating severe heart failure |
| 01/06/2010 | CN100577170C Application of pyrazolopyrimidine Src family tyrosine kinase inhibitor in preparing medicament for curing myocardial infarction |
| 01/06/2010 | CN100577169C Pulse controlled releasing Urapidil tablet and its preparing method |
| 01/06/2010 | CN100577168C Cream for treating alopecia and preparation method thereof |
| 01/06/2010 | CN100577167C Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating disease related to dysfunction of peripheral benzodiazepin receptors |
| 01/06/2010 | CN100577166C Drug formulation having improved oral tolerability |
| 01/06/2010 | CN100577165C Medicinal composition for treating cold wet numbness and preparation method thereof |
| 01/06/2010 | CN100577164C Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 01/06/2010 | CN100577163C Compounds effecting glucokinase |
| 01/06/2010 | CN100577162C Substituted oxazolidinones for combinational therapy |
| 01/06/2010 | CN100577161C New application of dendrobine |
| 01/06/2010 | CN100577160C Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 01/06/2010 | CN100577159C Myricetin dispersion tablets for treating cardio-cerebral blood vessel diseases and preparation method thereof |
| 01/06/2010 | CN100577158C Method for preparing Tengchasu dispersibletablet and its use |
| 01/06/2010 | CN100577157C Dispersant tablet containing hypolipidemic component and preparation method thereof |
| 01/06/2010 | CN100577152C 一种氯沙坦钾氢氯噻嗪片及其制备方法 One kind of losartan potassium and hydrochlorothiazide tablets prepared |
| 01/06/2010 | CN100577150C Abuse-proof dosage form |
| 01/06/2010 | CN100577148C Pharmaceutical composition comprising N((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and preparation process therefor comprising dry granulation |
| 01/06/2010 | CN100577136C Hydrous gel and production process and use of the hydrous gel |
| 01/06/2010 | CN100577036C Use of pullulan as a slowly digested carbohydrate |
| 01/05/2010 | US7642903 Trailer tire alert system |
| 01/05/2010 | US7642379 Aminoacetonitrile derivatives and their use for controlling parasites on warm-blooded animals |
| 01/05/2010 | US7642378 Lipid lowering biphenylcarboxamides |
| 01/05/2010 | US7642359 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 01/05/2010 | US7642358 Antidiabetic agents; modulate insulin drug resistance |
| 01/05/2010 | US7642355 Biphenyl compounds useful as muscarinic receptor antagonists |
| 01/05/2010 | US7642354 Polycyclic pyrazines as potassium ion channel modulators |
| 01/05/2010 | US7642353 crystallizing from a solvent selected from 1-propanol, 2-propanol, 1-butanol, ethyl acetate, acetonitrile |
| 01/05/2010 | US7642351 2,4-Pyrimidinediamine compounds and their uses |
| 01/05/2010 | US7642350 Purine derivatives |
| 01/05/2010 | US7642343 Micelles; complexes; stability; MALDI-TOF-MS |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642291 O-acyloxime derivatives, preparation method thereof, and pharmaceutical composition containing the same for prevention and treatment of cardiovascular disease |
| 01/05/2010 | US7642290 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 01/05/2010 | US7642289 Drugs for chronic pain |
| 01/05/2010 | US7642288 Topical application of adapalene for the long-term treatment of acne vulgaris |
| 01/05/2010 | US7642286 Stable pharmaceutical compositions containing pravastatin |
| 01/05/2010 | US7642284 Luminacin analogs and uses thereof |
| 01/05/2010 | US7642283 modulating the activity of the mitochrondrial permeability transition pore complex comprising exposing the complex to a compound such as 6-bromo-3-methylene-chroman-4-one |
| 01/05/2010 | US7642282 Alkoxylated 2-(4-aminophenylazo)-3,5-dicyano-4-methylthiophene derivative whiteners and polymer; laundry detergents; chromogen components fluoresce blue, red, or purple color when exposed to ultraviolet light, or they may absorb light to reflect these same shades; rinse added fabric softeners |
| 01/05/2010 | US7642281 Indolone compounds useful to treat cognitive impairment |
| 01/05/2010 | US7642280 Inhibitors of acyl glucosaminyl inositol amidase and methods of use |
| 01/05/2010 | US7642277 Non-nucleoside reverse transcriptase inhibitors |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642275 Histone deacetylase inhibitors |
| 01/05/2010 | US7642274 (+)-3-acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)propoxy)-5-methoxyphenyl]benzothiazoline; kappa -opioid receptor agonist |
| 01/05/2010 | US7642273 Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| 01/05/2010 | US7642272 Cannabinoid receptor ligands |
| 01/05/2010 | US7642271 aqueous, stable, injectable, sterile pharmaceutical solution containing an acid to solubilize the argatroban, free from dehydrated alcohol; sodium chloride osmotic-adjusting agent to enhance infusion properties; storage stable; anticoagulants |
| 01/05/2010 | US7642270 8-indan-5-yl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-5-oxo-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxylic acid ethyl ester; antiinflammatory, anticarcinogenic agent, cardiovascular disease; glomerulonephritis, immune nephritis, rheumatoid arthritis, asthma, pancreatitis, HIV infection, psoriasis |
| 01/05/2010 | US7642269 Pyrrolo[3,2-B]pyridine derivatives and processes for the preparation thereof |
| 01/05/2010 | US7642268 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
| 01/05/2010 | US7642267 Benzimidazole and pyridylimidazole derivatives |
| 01/05/2010 | US7642266 cancer, inflammation, arthritis, viral diseases, neurodegenerative diseases such as Alzheimer's disease, cardiovascular diseases, and fungal diseases |
| 01/05/2010 | US7642265 Benzimidazoles and analogs thereof as antivirals |
| 01/05/2010 | US7642263 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 01/05/2010 | US7642262 Arylipiperdinopropanol and arylipiperazinopropanol derivatives and pharmaceuticals containing the same |
| 01/05/2010 | US7642261 Treating bipolar disorder, mania, dementia, sexual dysfunction, eating disorders, fibromyalgia |
| 01/05/2010 | US7642260 N-acylsulfonamide derivatives; BCL-X1 protein inhibitors; anticarcinogenic agents; bladder cancer; for example, N-(4-(4-((4'-chloro(1,1'-biphenyl)-2-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)-propyl)amino)-3-nitrobenzenesulfonamide |
| 01/05/2010 | US7642259 glucokinase activator 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide or a salt thereof; chemical synthesis to obtain antidiabetic agent |
| 01/05/2010 | US7642258 Glaucoma and/or ocular hypertension; stability; lower dosage |
| 01/05/2010 | US7642257 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors |
| 01/05/2010 | US7642256 schizophrenia; 1-[4-(4-morpholinylcarbonyl)phenyl]-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole; administered alone or with another antipsychotic drug |
| 01/05/2010 | US7642255 Compounds and compositions as protein kinase inhibitors |
| 01/05/2010 | US7642254 ATM inhibitors |
| 01/05/2010 | US7642253 Histone deacetylase inhibitors |
| 01/05/2010 | US7642252 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 01/05/2010 | US7642251 Compounds for the treatment of hepatitis C |
| 01/05/2010 | US7642249 Dihydrogen phosphate salt of a prostaglandin D2 receptor antagonist |
| 01/05/2010 | US7642248 Devices and processes for distribution of genetic material to mammalian limb |
| 01/05/2010 | US7642247 1,3,5-triazines for treatment of viral diseases |
| 01/05/2010 | US7642235 Macrocyclic peptides active against the hepatitis C virus |